Journal of Medicinal Chemistry · 2008 · 84 citations · 9 references
PharmacyMedicinal ChemistryPharmacologyDrug DiscoveryMolecular VirologyPharmacophore ModelingAntiretroviral TherapyAntiviral PharmacologyAntiviral TherapyLigand BindingMolecular DockingProtein-ligand DockingAntiviral Drug DesignAntiviral TherapeuticsDocking-based Drug DesignHiv Antiretroviral TherapyMolecular Docking Of InhibitorsNuclear Export Of Localized RnaNuclear Export Of Noncoding RnaSmall Nuclear Rna Export
HIV-1 replication has been inhibited by using a compound able to target the human cellular cofactor DEAD-box ATPase DDX3, essential for HIV-1 RNA nuclear export. This compound, identified by means of a computational protocol based on pharmacophoric modeling and molecular docking calculations, represents the first small molecule with such a mechanism of action and could lay the foundations for a pioneering approach for the treatment of HIV-1 infections.
9
Requirement of DDX3 DEAD Box RNA Helicase for HIV-1 Rev-RRE Export Function
Venkat S. R. K. Yedavalli, Christine Neuveut, Ya‐Hui Chi et al. · Cell · 2004 · 553 citations · Full text